申请人:Washington University
公开号:US10844023B2
公开(公告)日:2020-11-24
Compositions comprising small molecule mitofusin agonists are described. The mitofusin modulating agents are useful for treating diseases or disorders associated with a mitochondria-associated disease, disorder, or condition such as diseases or disorders associated with mitofusin 1 (Mfn1) and/or mitofusin 2 (Mfn2), or mitochondrial dysfunction. Methods of treatment, pharmaceutical formulations, and screening methods for identifying compounds that regulate mitochondrial function are also described.
本文描述了包含小分子丝裂霉素激动剂的组合物。丝裂素素调节剂可用于治疗与线粒体相关的疾病、紊乱或病症,如与丝裂素素1(Mfn1)和/或丝裂素素2(Mfn2)或线粒体功能障碍相关的疾病或紊乱。还描述了治疗方法、药物制剂和用于鉴定调节线粒体功能的化合物的筛选方法。